CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma

BACKGROUND: Thymic squamous cell carcinoma and type B3 thymoma are primary neoplasms of the anterior mediastinum that are sometimes difficult to differentiate from one another histologically. However, only a few immunohistochemical markers are available for the differential diagnosis. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanamori, Koichiro, Suina, Kentaro, Shukuya, Takehito, Takahashi, Fumiyuki, Hayashi, Takuo, Hara, Kieko, Saito, Tsuyoshi, Mitsuishi, Yoichiro, Shimamura, Shoko Sonobe, Winardi, Wira, Tajima, Ken, Ko, Ryo, Mimori, Tomoyasu, Asao, Tetsuhiko, Itoh, Masayoshi, Kawaji, Hideya, Suehara, Yoshiyuki, Takamochi, Kazuya, Suzuki, Kenji, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125782/
https://www.ncbi.nlm.nih.gov/pubmed/36924358
http://dx.doi.org/10.1111/1759-7714.14853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125782/
https://www.ncbi.nlm.nih.gov/pubmed/36924358
http://dx.doi.org/10.1111/1759-7714.14853

Ejemplares similares